Details for New Drug Application (NDA): 074699
✉ Email this page to a colleague
NDA 074699 describes ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, which is a drug marketed by Gavis Pharms and Watson Labs and is included in two NDAs. Additional details are available on the ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE profile page.
The generic ingredient in ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.
The generic ingredient in ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.
Summary for 074699
| Tradename: | ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | acetaminophen; pentazocine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 650MG;EQ 25MG BASE | ||||
| Approval Date: | Mar 24, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
